Research Article
Role of Sclerotherapy in the Management of Various Types of Vascular Anomalies in a Tertiary Health Care Center
Sharma N* and Sharma MS
Department of Radiodiagonisis, SRMS-IMS, India
*Corresponding author: Sharma N, Department of Radiodiagonisis, SRMS-IMS, Bhojipura, Bareilly, India
Copyright: © 2019 Sharma N, et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is is properly cited.
Article Information: Submission: 03/07/2019; Accepted: 10/10/2019; Published: 14/10/2019
Abstract
Introduction: In the population the vascular malformations are around 4.5%. These malformations can be classified into arterial malformations, venous
malformations, arterio-venous malformations, lymphatic malformations, and capillary malformations and combined vascular defects.
Aims and objectives: To study the Role of sclerotherapy in the management of various types of vascular anomalies at a tertiary health care center
Methodology: This was a cross-sectional study carried out in the department of Interventional Radiology of a tertiary health care centre during the six
month period i.e. august 2018 to January 2019. In the six month period there were 50 patients enrolled for study. Patients had undergone Sclerotherapy
with sodium tetradecyl sulfate alone (Group A) (n=25) versus sodium tetradecyl sulfate and lipiodol (Group B) (n=25) randomly. The statistical analysis was
done by SPSS 19 version software.
Result: The majority of the patients in the age group of <10 years were 46%, followed by 10-20 years were 30%, 20-30 years were 14%, 30-40 years
were 10%. The majority of the patients were Females i.e. 64% and males 36%. The various sites of vascular malformations found were Upper limb extremity
in 38%, followed by Head and Neck in 28%, Lower limb extremity in 16%, Buttocks in 10%, Genital area in 8%.The majority of the patients with successful
Sclerotherapy in first attempt were in Group B i.e. 38% as compared 24% in Group A while 26% in Group A versus only 10% in Group B patients required
Re-embolization. This observed difference was statistically significant (X2
=5.11, df=1, p<0.02).No major complications were found in our study but the mild
complications were comparable in both the groups (X2
=0.46, df=6, p>0.05)
Conclusion: It can be concluded from our study that both the groups of sclerosants were effective in the treatment of various malformations but
success in first attempt was more to combined sodium tetradecyl sulfate and lipiodol versus sodium tetradecyl sulfate alone and both the groups were having
comparable complications